Importantly, there are also GLA variants that result in reduced AGAL enzyme activity but do not lead to FD: the residual enzyme activity is apparently sufficient to prevent substrate accumulation, which is the driver of major lysosomal dysfunction in FD [8]. Here, GLA is linked to Fabry disease.